semaglutide compound ban Fifth Circuit probes FDA on compounded GLP-1s FDA is moving to restrict

Discover the eligibility criteria for donating plasma and make a positive impact on lives

In this review, we outline selected recent and suggested future attempts to address the evolving profile of the person with type 1 diabetes

Improve sleep, energy, workouts, and recovery with physician-guided treatment.

Health plan cost trend dramatically fell in 2022, thereafter rebounding as patients returned to medical care after a period of medical distancing, avoiding in-person care whether in hospital outpatient departments or doctors offices

Learn the differences in safety, regulation, and dosing

Real-world data show early discontinuation of GLP-1 therapy is linked to higher risks of coronary artery disease and heart failure.